iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$14.71 USD
-0.27 (-1.77%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $14.69 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -1.05 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 82.69% |
ABR | 1.00 |
Earnings ESP
|
-1.19% |
---|---|
Current Year | -4.22 |
Next Year | -5.83 |
EPS (TTM) | -3.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.20M | 4.20M | 27.53M | 37.41M |
# of Estimates | 1 | 1 | 3 | 1 |
High Estimate | 4.20M | 4.20M | 35.00M | 37.41M |
Low Estimate | 4.20M | 4.20M | 12.60M | 37.41M |
Year ago Sales | 0.00M | 0.00M | 12.60M | 27.53M |
Year over Year Growth Est. | NA | NA | 118.60% | 35.87% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.05 | -1.12 | -4.22 | -5.83 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -1.21 | -1.25 | -5.92 | -8.35 |
High Estimate | -0.87 | -0.96 | -3.32 | -3.19 |
Low Estimate | -1.21 | -1.25 | -5.92 | -8.35 |
Year ago EPS | -0.90 | -0.85 | -3.15 | -4.22 |
Year over Year Growth Est. | -16.67% | -31.76% | -33.97% | -38.06% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 2 | 1 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.05 | -1.12 | -4.22 | -5.83 |
7 Days Ago | -1.05 | -1.11 | -4.57 | -5.76 |
30 Days Ago | -1.05 | -1.11 | -4.57 | -5.76 |
60 Days Ago | -1.05 | -1.11 | -4.57 | -5.76 |
90 Days Ago | -1.08 | -1.23 | -4.70 | -5.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.07 | -1.14 | -3.43 | -5.63 |
Zacks Consensus Estimate | -1.05 | -1.12 | -4.22 | -5.83 |
Earnings ESP | -1.19% | -1.56% | 18.92% | 3.43% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -1.07 | -0.85 | -0.90 | NA |
Estimate | -1.04 | -1.02 | -1.03 | -1.20 | NA |
Difference | 0.86 | -0.05 | 0.18 | 0.30 | 0.32 |
Surprise | 82.69% | -4.90% | 17.48% | 25.00% | 30.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more